Categories Earnings, Health Care
Earnings Summary: A snapshot of McKesson Corporation’s Q1 2024 report
McKesson Corporation (NYSE: MCK), a diversified healthcare service company that operates in partnership with biopharma companies, care providers, pharmacies, and governments, on Wednesday reported financial results for the first quarter of 2024.
- Total revenues came in at $74.5 billion in the first three months of 2024, up 11% year-over-year
- Earnings per share from continuing operations was $7.02 in Q1, compared to $5.25 last year
- Adjusted earnings per share increased 25% year-over-year to $7.27
- McKesson’s board of directors approved a $6.0 billion increase to the company’s share repurchase program
- For fiscal 2024, the management expects adjusted earnings per share to be between $26.55 and $27.35
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was
